Menu
  • Join
  • Login
  • Contact
 

Search abstracts / presentations


Developing evidence to inform the clinical utility and cost-effectiveness of pharmacogenomic markers: challenges and opportunities

  • In: SYMPOSIUM: ENABLING PERSONALIZED MEDICINE: GETTING THE FRAMEWORK RIGHT? on Tuesday, 15 April 2014, 10:30-12:00
  • At: PSWC, Melbourne (Australia) (2014)
  • Type: Presentation
  • By: SORICH, Michael (Flinders University, Clinical Pharmacology, Adelaide, Australia)
  • Abstract:

    Background: Despite extensive research the clinical translation of pharmacogenomics has been less than expected. One of the key factors identified is the quality of the evidence supporting the clinical utility and cost-effectiveness of pharmacogenomic markers. A better general appreciation of these issues is valuable in setting more realistic..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 28 September 2023

FIP Congresses